NCT03980821View on ClinicalTrials.gov

A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

July 4, 2019

Primary Completion Date

September 7, 2020

Study Completion Date

September 7, 2020

Conditions

Advanced Solid Malignancies

Interventions

DRUG

AZD4635

AZD4635 taken orally

Trial Locations (2)

104-0045

Research Site, Chūōku

277-8577

Research Site, Kashiwa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY